The Results of Radiation Therapy of Limited Stage Small Cell Lung Cancer

1983년 4월부터 1991년 9월까지 가톨릭 의과대학 강남성모병원 치료방사선과에서 국한된 폐소세포암으로 확진되어 방사선치료받은 32명의 환자를 대상으로 치료성적을 후향 분석하였다. 이중 5명은 방사선 치료 단독으로 치료받았으며 27명은 화확요법과 방사선치료 병용요법을 하였다. 남녀의 비는 4.3:1 이었으며 연령분포는 24세에서 78세였다 (중앙값 : 63세), 6 MV X 선에의한 방사선치료선량은 일일 160~180 cGyTLr 치료하여 총 1000-6660 cGy (중앙값 4500 cGy) 였다. 치료후 완전관해율은 37.5% (12/32), 부분관해율은 34.4% (11/32)였고, 무반응은 28.1% (0/32)였다. 생존기간의 중앙값은 10개월이었고 1년 생존율과 2년생존율은 각 59.4%와 28.1% 였다. 1년생존율을 유의하게 증가시키는 요소로서는 70이상의 Karnofsky 수행상태 (p<0.04), 화확요법의 병향 (CAV, PV, CAV+PV) (p<0.04), 화확요법 6회이상 (p<0.007), 45 Gy 이상의 방사선량 (p<0.03)와 방사선치료에 반응있었던 경우 (CR+PR) (p<0.003)등이었다. 나이, 성별, 상대정맥증후군, 예방적 전뇌조사 및 방사선 치료기간은 유의한 영향을 미치지 않았다. 방사선 치료에 의한 부작용은 식도염이 34% (11명), 전신피로 28% (9명)에서 있었으며 오심 구같은 위장관 증상은 15%(5명) 그리고 백혈구 감소증이 3%(1명)에서 관찰되었다.

A retrospective analysis of various characteristics in 32 limited stage samall cell lung cancer patients treated at the Department of Therapeutic Radiology in Kangnam st. Mary's Hospital, Catholic Universtiy Medical College from April 1983 to september 1991, was carried out to identify factors which had prognostic significance for survival from initiation of radiation therapy. There were 26 men and 6 women, Median age was 63 years (range: 24-78 years). The follow up duration was 1.5 to 44 months (median: 9 months). External radiation therapy was done with daily 160-180 cGy, 5 fraction/week, total of 100-6660 cGy (mdian: 4500 cGy) to the mediastinum by 6 MV linear accelerator. Of 32 patients, 27 (84.4%) patients were treated with combined modality (chemotherapy plus radiation therapy), and 5 (15.6%) patients were treated with radiation therapy only. Complete responders were 12 patients (37.5%), partial responders were 11 (34.4%), and no responders were 9 (28.1%). Karnofsky performance status ocer 70 (p<0.04), chemotherapy regimen (CAV, PV, and CAV=PV) (p<0.03), and radiation terapy responder (CR+PR) (p<0.003) showed a significantly favorable influence on 1 year survival rate. Age (P=0.545), sex (p=0.666), presence of superior vena cava syndrome (p=0.719), prophylactic cranial irradiation (p=0.217), and radiation therapy duration (p=0.491) had no effect on survival. Radiation induced side effects were transient esophagitis in 11 (34%), general weakness in 9 (28%), gastrointestinal symptoms in terms of nausea, vomiting and indigestion in 5 (15%) and leukopenia in 1 (3%)